NanoViricides, Inc. (NASDAQ:NNVC)

BRIEF

published on 11/03/2025 at 14:35, 9 months 11 days ago

NanoViricides to Present at Spartan Capital Investor Conference 2025

NanoViricides NV-387 Clinical Trials Antiviral Drugs Spartan Capital Conference
PRESS RELEASE

published on 11/03/2025 at 14:30, 9 months 11 days ago

NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd
NanoViricides, Inc. to present groundbreaking antiviral drug NV-387 at Spartan Capital Investor Conference. CEO Diwan to update on drug pipeline & Platform Technologies for licensing

NanoViricides NV-387 Clinical Trial Antiviral Drug Spartan Capital Investor Conference
BRIEF

published on 10/29/2025 at 13:50, 9 months 16 days ago

NV-387: A Promising Antiviral Agent for Measles

NanoViricides NV-387 Clinical Trials Antiviral Research Measles Treatment
BRIEF

published on 10/29/2025 at 13:50, 9 months 16 days ago

NV-387 : un agent antiviral prometteur contre la rougeole

NanoViricides NV-387 Essais Cliniques Recherche Antivirale Traitement De La Rougeole
PRESS RELEASE

published on 10/29/2025 at 13:45, 9 months 16 days ago

Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive
NanoViricides, Inc. announced progress in antiviral research with their drug NV-387 showing potent activity against Measles virus. Clinical trials have shown safety and effectiveness, positioning for emergency use

NanoViricides NV-387 Clinical Trials Antiviral Research Measles Virus
BRIEF

published on 10/27/2025 at 13:50, 9 months 18 days ago

NanoViricides sera présenté à la conférence PODD 2025

NanoViricides NV-387 Biotechnologie Essais Cliniques Médicament Antiviral
BRIEF

published on 10/27/2025 at 13:50, 9 months 18 days ago

NanoViricides Set to Present at PODD 2025 Conference

NanoViricides NV-387 Biotechnology Clinical Trials Antiviral Drug
PRESS RELEASE

published on 10/27/2025 at 13:45, 9 months 18 days ago

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27
NanoViricides, Inc. to present at PODD 2025 Conference with focus on revolutionary broad-spectrum antiviral drugs in development for various viral infections

Respiratory Viral Infections NV-387 Antiviral Drugs NanoViricides, Inc. PODD 2025 Conference
BRIEF

published on 10/22/2025 at 14:50, 9 months 23 days ago

Le NV-387 s'avère prometteur contre la rougeole et protège les poumons

NV-387 Essais Cliniques Antiviral Rougeole Protection Pulmonaire
BRIEF

published on 10/22/2025 at 14:50, 9 months 23 days ago

NV-387 Shows Promise Against Measles, Protects Lungs

NV-387 Clinical Trials Antiviral Lung Protection Measles

Published on 08/15/2026 at 00:50, 8 hours 25 minutes ago

Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 9 hours ago

Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 9 hours 30 minutes ago

AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 9 hours 50 minutes ago

NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 10 hours 15 minutes ago

Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call

View all ACCESSWIRE

Published on 08/15/2026 at 08:05, 1 hour 10 minutes ago

SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:29, 14 hours 46 minutes ago

Designated Persons Notifications
Published on 08/14/2026 at 18:29, 14 hours 46 minutes ago

Designated Persons Notifications
Published on 08/14/2026 at 18:15, 15 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 17 hours 10 minutes ago

GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON

View all EQS

Published on 08/13/2026 at 18:00, 1 day 15 hours ago

Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 15 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 15 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 15 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 15 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

View all LES ECHOS COMFI WIRE

News